Clinical Trial Update: Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pharmacokinetics of adalimumab with methotrexate for ulcerative colitis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Alimentiv Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2021-06-23